Here are five takeaways:
1. The stock was sold at an average price of $19.70, for a total value of $819,007.
2. Following the transaction, Mr. Cole now owns 9,087 shares of the company’s stock, valued at $179,013.
3. K2M has a 52-week low of $16.40 and a 52-week high of $26.29.
4. The company has a 50-day moving average price of $18.75 and a 200-day moving average price of $21.92.
5. K2M’s market cap is $803.02 million.
More articles on devices:
SeaSpine Q3 revenue drops 3%, net loss hits $133M: 5 key notes
Amedica revenue drops 19% in Q3: 5 things to know
VertiFlex, Xtant Medical, Orthofix & more — 23 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
